By Ambar Corporan

Research will be emphasized in the NSU College of Allopathic Medicine's innovative curriculum. Pictured: Johannes W. Vieweg, M.D., FACS, founding dean, speaks with Julia James, Ph.D, post-doctoral researcher, and Ron Thomas, B.Sc., research assistant, in the NSU Cell Therapy Institute laboratory.

FOR IMMEDIATE RELEASE

Research will be emphasized in the NSU College of Allopathic Medicine’s innovative curriculum. Pictured: Johannes W. Vieweg, M.D., FACS, founding dean, speaks with Julia James, Ph.D, post-doctoral researcher, and Ron Thomas, B.Sc., research assistant, in the NSU Cell Therapy Institute laboratory.

FORT LAUDERDALE/DAVIE, Fla. – The Nova Southeastern University (NSU) College of Allopathic Medicine has received preliminary accreditation – a major milestone that allows the new medical school to accept an inaugural class of 50 students into its innovative and coveted Doctor of Medicine (M.D.) program, which will matriculate in August 2018.

The accreditation follows a site visit and a favorable review by a survey team of educators from the Liaison Committee on Medical Education (LCME), the organization that accredits M.D. programs in the U.S. and Canada. The college is now the eighth M.D. program in Florida and one of only 148 in the United States.

“The accreditation decision is a transformational moment in the history of NSU which brings the university another step closer toward NSU’s Vision 2020 and its goal of becoming a nationally recognized, top-tier university of teaching, research, service, and learning,” said NSU President Dr. George Hanbury.

“NSU has made remarkable commitments …read more

Source:: NSU News